Cetera Investment Advisers Invests $1.32 Million in Tempus AI, Inc. (NASDAQ:TEM)

Key Points

• Cetera Investment Advisers has invested approximately $1.32 million in Tempus AI by acquiring over 27,000 shares during the first quarter of the year, as disclosed in their recent Form 13F filing.
• Insider transactions indicate significant selling activity, with Erik Phelps and Eric P. Lefkofsky selling over 200,000 shares combined, representing notable decreases in their respective positions.
• Despite posting a negative EPS of ($0.22) with revenue of $314.64 million in the last quarter, Tempus AI's revenue increased by 89.5% compared to the same quarter last year, surpassing analysts' expectations.

Cetera Investment Advisers purchased a new position in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 27,294 shares of the company's stock, valued at approximately $1,317,000.

Other institutional investors have also recently made changes to their positions in the company. Operose Advisors LLC bought a new stake in Tempus AI in the 4th quarter worth $25,000. Cherry Tree Wealth Management LLC bought a new stake in Tempus AI during the 1st quarter valued at about $31,000. Continuum Advisory LLC purchased a new stake in Tempus AI in the first quarter worth approximately $39,000. Bartlett & CO. Wealth Management LLC boosted its holdings in Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock worth $39,000 after purchasing an additional 400 shares during the last quarter. Finally, Signaturefd LLC purchased a new stake in Tempus AI in the first quarter worth approximately $48,000. Institutional investors own 24.22% of the company's stock.

Insider Buying and Selling at Tempus AI

In related news, EVP Erik Phelps sold 51,317 shares of Tempus AI stock in a transaction on Monday, June 16th. The shares were sold at an average price of $72.56, for a total value of $3,723,561.52. Following the sale, the executive vice president owned 97,779 shares of the company's stock, valued at approximately $7,094,844.24. This trade represents a 34.42% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Eric P. Lefkofsky sold 166,250 shares of Tempus AI stock in a transaction on Monday, July 28th. The shares were sold at an average price of $62.87, for a total transaction of $10,452,137.50. Following the completion of the sale, the chief executive officer directly owned 9,274,033 shares in the company, valued at $583,058,454.71. This represents a 1.76% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 758,772 shares of company stock worth $51,005,175. 27.60% of the stock is currently owned by insiders.

Tempus AI Stock Performance

Shares of Tempus AI stock opened at $60.87 on Monday. Tempus AI, Inc. has a 52 week low of $31.36 and a 52 week high of $91.45. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. The firm has a market capitalization of $10.54 billion, a P/E ratio of -51.15 and a beta of 4.98. The company has a 50 day moving average price of $62.47 and a 200 day moving average price of $58.08.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. The company had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 157.53%. Tempus AI's revenue for the quarter was up 89.5% compared to the same quarter last year. During the same period last year, the firm posted ($6.86) EPS. Sell-side analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on TEM. Bank of America boosted their target price on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research report on Wednesday, June 25th. BTIG Research assumed coverage on shares of Tempus AI in a research note on Friday. They set a "buy" rating and a $60.00 price target on the stock. Guggenheim increased their target price on shares of Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Needham & Company LLC restated a "buy" rating and issued a $70.00 price target on shares of Tempus AI in a report on Friday. Finally, Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a report on Friday. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, Tempus AI presently has an average rating of "Moderate Buy" and an average target price of $65.09.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.